124 related articles for article (PubMed ID: 10414924)
1. Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant.
Nieto Y; Ross M; Gianani R; Shpall EJ; Cagnoni PJ; Bearman SI; Jones RB
Bone Marrow Transplant; 1999 Jun; 23(12):1323-4. PubMed ID: 10414924
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma: the prevalence and impacts on outcomes : EBV and CMV reactivation post allo-HCT in NHL.
Ding Y; Ru Y; Song T; Guo L; Zhang X; Zhu J; Li C; Jin Z; Huang H; Tu Y; Xu M; Xu Y; Chen J; Wu D
Ann Hematol; 2021 Nov; 100(11):2773-2785. PubMed ID: 34480615
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus Infection in Pediatric Hematopoietic Stem Cell Transplantation: Risk Factors for Primary Infection and Cases of Recurrent and Late Infection at a Single Center.
Rowe RG; Guo D; Lee M; Margossian S; London WB; Lehmann L
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1275-1283. PubMed ID: 27090959
[TBL] [Abstract][Full Text] [Related]
4. Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation.
Takenaka K; Onishi Y; Mori T; Hirakawa T; Tada Y; Uchida N; Kobayashi T; Kanda Y; Ozawa Y; Ota S; Iida H; Fukushima K; Kimua T; Fukuda T; Atsuta Y; Matsuto K; Yamazaki H; Nakasone H
Transplant Cell Ther; 2021 Jan; 27(1):82.e1-82.e8. PubMed ID: 33039517
[TBL] [Abstract][Full Text] [Related]
5. T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation.
Toya T; Taguchi A; Kitaura K; Misumi F; Nakajima Y; Otsuka Y; Konuma R; Adachi H; Wada A; Kishida Y; Konishi T; Nagata A; Yamada Y; Marumo A; Noguchi Y; Yoshifuji K; Mukae J; Inamoto K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Ohashi K; Suzuki R; Nagamatsu T; Doki N
Sci Rep; 2020 Dec; 10(1):22218. PubMed ID: 33335252
[TBL] [Abstract][Full Text] [Related]
6. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
[TBL] [Abstract][Full Text] [Related]
7. An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Pascual MJ; Gago B; Piñana JL; Hernández-Boluda JC; Vázquez L; García M; Serrano D; Hernández M; Albert E; Solano C; Navarro D
Med Microbiol Immunol; 2020 Feb; 209(1):15-21. PubMed ID: 31478067
[TBL] [Abstract][Full Text] [Related]
8. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation.
Cwynarski K; Ainsworth J; Cobbold M; Wagner S; Mahendra P; Apperley J; Goldman J; Craddock C; Moss PA
Blood; 2001 Mar; 97(5):1232-40. PubMed ID: 11222365
[TBL] [Abstract][Full Text] [Related]
9. [Management of cytomegalovirus infection after hematopoietic stem cell transplantation].
Mori T
Rinsho Ketsueki; 2019; 60(9):1337-1340. PubMed ID: 31597861
[TBL] [Abstract][Full Text] [Related]
10. Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.
Junghanss C; Boeckh M; Carter RA; Sandmaier BM; Maris MB; Maloney DG; Chauncey T; McSweeney PA; Little MT; Corey L; Storb R
Blood; 2002 Mar; 99(6):1978-85. PubMed ID: 11877269
[TBL] [Abstract][Full Text] [Related]
11. The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches.
Jain NA; Lu K; Ito S; Muranski P; Hourigan CS; Haggerty J; Chokshi PD; Ramos C; Cho E; Cook L; Childs R; Battiwalla M; Barrett AJ
Cytotherapy; 2014 Jul; 16(7):927-33. PubMed ID: 24831837
[TBL] [Abstract][Full Text] [Related]
12. The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a systematic review and meta-analysis.
Chuleerarux N; Nematollahi S; Thongkam A; Dioverti MV; Manothummetha K; Torvorapanit P; Langsiri N; Worasilchai N; Plongla R; Chindamporn A; Sanguankeo A; Permpalung N
Clin Microbiol Infect; 2022 Mar; 28(3):332-344. PubMed ID: 34752926
[TBL] [Abstract][Full Text] [Related]
13. Fatal cytomegalovirus interstitial pneumonia following autologous peripheral blood stem cell transplantation. Fukuoka Bone Marrow Transplantation Group.
Nagafuji K; Eto T; Hayashi S; Tokunaga Y; Gondo H; Niho Y
Bone Marrow Transplant; 1998 Feb; 21(3):301-3. PubMed ID: 9489656
[TBL] [Abstract][Full Text] [Related]
14. [Application of real time polymerase chain reaction to the diagnosis and treatment of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
Chen H; Liu KY; Xu LP; Liu DH; Chen YH; Zhao XS; Yu L; Han W; Zhang XH; Wang Y; Chen Y; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Feb; 30(2):77-81. PubMed ID: 19563015
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
16. Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic stem cell transplantation: a real-world review.
Tan BH; Chlebicka NL; Low JG; Chong TY; Chan KP; Goh YT
Transpl Infect Dis; 2008 Oct; 10(5):325-32. PubMed ID: 18627578
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
He J; Chen BA; Ni M; Wu X; Ding JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1371-6. PubMed ID: 25338591
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus DNAemia and treatment following allogeneic stem cell transplantation with a focus on long-term outcome.
Lindahl JK; Woxenius S; Brune M; Andersson R
Scand J Infect Dis; 2010 Sep; 42(9):691-8. PubMed ID: 20429709
[TBL] [Abstract][Full Text] [Related]
19. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
[TBL] [Abstract][Full Text] [Related]
20. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT.
Trenschel R; Ross S; Hüsing J; Ottinger H; Elmaagacli A; Roggendorf M; Schaefer UW; Runde V
Bone Marrow Transplant; 2000 Mar; 25(6):665-72. PubMed ID: 10734302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
